[Treatment of arterial hypertension in patients with benign prostatic hyperplasia].
Arterial hypertension (AH) is encounted in 20-30% of patients with benign prostatic hyperplasia (BPH). Alpha1-adrenoblockers have limited application in such patients and should be used as a first-line therapy only in those BPH patients who already receive them for BPH. In other cases AH is managed with thiaside diuretics, beta-adrenoblockers, ACE inhibitors or calcium antagonists. A drug of choice for correction of urination disorders in BPH hypertensive patients is alpha1A-adrenoblocker tamsulozin.